Literature DB >> 17220877

Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer.

Yuka Okada1, Yuko Ueshin, Ayako Isotani, Tomoko Saito-Fujita, Hisako Nakashima, Kazushi Kimura, Akira Mizoguchi, Masatsugu Oh-Hora, Yoshiko Mori, Masato Ogata, Robert G Oshima, Masaru Okabe, Masahito Ikawa.   

Abstract

Placental dysfunction underlies many complications during pregnancy, and better understanding of gene function during placentation could have considerable clinical relevance. However, the lack of a facile method for placenta-specific gene manipulation has hampered investigation of placental organogenesis and the treatment of placental dysfunction. We showed previously that transduction of fertilized mouse eggs with lentiviral vectors leads to transgene expression in both the fetus and the placenta. Here we report placenta-specific gene incorporation by lentiviral transduction of mouse blastocysts after removal of the zona pellucida. All of the placentas analyzed, but none of the fetuses, were transgenic. Application of this method substantially rescued mice deficient in Ets2, Mapk14 (also known as p38alpha) and Mapk1 (also known as Erk2) from embryonic lethality caused by placental defects. Ectopic expression of Mapk11 also complemented Mapk14 deficiency during placentation.

Entities:  

Mesh:

Year:  2007        PMID: 17220877     DOI: 10.1038/nbt1280

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  47 in total

Review 1.  Transposase-mediated gene modulation in the placenta.

Authors:  Marlee Elston; Johann Urschitz
Journal:  Placenta       Date:  2017-07-29       Impact factor: 3.481

Review 2.  Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface.

Authors:  M J Soares; D Chakraborty; M A Karim Rumi; T Konno; S J Renaud
Journal:  Placenta       Date:  2012-01-28       Impact factor: 3.481

3.  Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model.

Authors:  Keiichi Kumasawa; Masahito Ikawa; Hiroyasu Kidoya; Hidetoshi Hasuwa; Tomoko Saito-Fujita; Yuka Morioka; Nobuyuki Takakura; Tadashi Kimura; Masaru Okabe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 4.  Interferon-tau, a Type 1 interferon involved in maternal recognition of pregnancy.

Authors:  R Michael Roberts
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

5.  Transcriptional Regulation of the First Cell Fate Decision.

Authors:  Catherine Rhee; Jonghwan Kim; Haley O Tucker
Journal:  J Dev Biol Regen Med       Date:  2017-10-26

6.  Preeclampsia: animal models for a human cure.

Authors:  Mira Aubuchon; Laura C Schulz; Danny J Schust
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

7.  Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy.

Authors:  Nick Goeden; Alexandre Bonnin
Journal:  Nat Protoc       Date:  2012-12-13       Impact factor: 13.491

8.  The involvement of proline-rich 15 in early conceptus development in sheep.

Authors:  Scott H Purcell; Jeremy D Cantlon; Casey D Wright; Luiz E Henkes; George E Seidel; Russell V Anthony
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

9.  In vivo genetic manipulation of the rat trophoblast cell lineage using lentiviral vector delivery.

Authors:  Dong-Soo Lee; M A Karim Rumi; Toshihiro Konno; Michael J Soares
Journal:  Genesis       Date:  2009-07       Impact factor: 2.487

10.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.